Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates—a multicentre, observational survey in critically ill patientsVOGELAERS, Dirk; DE BELS, David; FORET, Frédéric et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 4, pp 375-381, issn 0924-8579, 7 p.Article

Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapyFALAGAS, Matthew E; KASIAKOU, Sofia K; RAFAILIDIS, Petros I et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 57, Num 6, pp 1251-1254, issn 0305-7453, 4 p.Article

Considerations of antibiotic therapy duration in community-and hospital-acquired bacterial infectionsESPOSITO, Silvano; ESPOSITO, Isabella; LEONE, Sebastiano et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 11, pp 2570-2575, issn 0305-7453, 6 p.Article

Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromesBORER, A; GILAD, T; MEYDAN, N et al.Clinical microbiology and infection. 2004, Vol 10, Num 10, pp 911-916, issn 1198-743X, 6 p.Article

Two decades of imipenem therapyRODLOFF, A. C; GOLDSTEIN, E. J. C; TORRES, A et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 5, pp 916-929, issn 0305-7453, 14 p.Article

Appropriate and timely empirical antimicrobial treatment of ICU infections : A role for carbapenemsCOLARDYN, F.Acta Clinica Belgica. 2005, Vol 60, Num 2, pp 51-62, issn 0001-5512, 12 p.Article

Ventilator-associated pneumonia in a tertiary care ICU : Analysis of risk factors for acquisition and mortalityMYNY, D; DEPUYDT, P; COLARDYN, F et al.Acta Clinica Belgica. 2005, Vol 60, Num 3, pp 114-121, issn 0001-5512, 8 p.Article